Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study

Autor: Michela Garon, Luca Weis, Eleonora Fiorenzato, Francesca Pistonesi, Annachiara Cagnin, Alessandra Bertoldo, Mariagiulia Anglani, Diego Cecchin, Angelo Antonini, Roberta Biundo

Publikováno v: Frontiers in Neurology, Vol 12 (2022)

BackgroundMild cognitive impairment in Parkinson's disease (PD-MCI) is associated with faster cognitive decline and conversion to dementia. There is uncertainty about the role of β-amyloid (Aβ) co-pathology and its contribution to the variability i

Externí odkaz: https://doaj.org/article/0b88b7a150d64ea9aa06e6e22cb044f7

Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson’s disease (PD_Manager): study protocol for a pilot randomised controlled trial

Autor: Angelo Antonini, Giovanni Gentile, Manuela Giglio, Andrea Marcante, Heather Gage, Morro M. L. Touray, Dimitrios I. Fotiadis, Dimitris Gatsios, Spyridon Konitsiotis, Lada Timotijevic, Bernadette Egan, Charo Hodgkins, Roberta Biundo, Clelia Pellicano, on behalf of the PD_Manager consortium

Publikováno v: Trials, Vol 19, Iss 1, Pp 1-11 (2018)

Abstract Background Parkinson’s disease is a degenerative neurological condition causing multiple motor and non-motor symptoms that have a serious adverse effect on quality of life. Management is problematic due to the variable and fluctuating natu

Externí odkaz: https://doaj.org/article/4ab0c843a5d94e0fbe218b2fd78e349a

Correction to: A case of childhood‑onset dystonia‑parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation

Autor: Federica Garrì, Dario Ciprietti, Lisa Lerjefors, Andrea Landi, Manuela Pilleri, Roberta Biundo, Leonardo Salviati, Miryam Carecchio, Angelo Antonini

Publikováno v: Neurological Sciences.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e252dc4cf55777944a908f62bf650227
https://doi.org/10.1007/s10072-023-06864-z

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease

Autor: Andrea Quattrone, Maria G. Bianco, Angelo Antonini, David E. Vaillancourt, Klaus Seppi, Roberto Ceravolo, Antonio P. Strafella, Gioacchino Tedeschi, Alessandro Tessitore, Roberto Cilia, Maurizio Morelli, Salvatore Nigro, Basilio Vescio, Pier Paolo Arcuri, Rosa De Micco, Mario Cirillo, Luca Weis, Eleonora Fiorenzato, Roberta Biundo, Roxana G. Burciu, Florian Krismer, Nikolaus R. McFarland, Christoph Mueller, Elke R. Gizewski, Mirco Cosottini, Eleonora Del Prete, Sonia Mazzucchi, Aldo Quattrone

Publikováno v: Movement disorders (Online) 37 (2022): 1272–1281. doi:10.1002/mds.28992
info:cnr-pdr/source/autori:Quattrone A.; Bianco M.G.; Antonini A.; Vaillancourt D.E.; Seppi K.; Ceravolo R.; Strafella A.P.; Tedeschi G; Tessitore A.; Cilia R.; Morelli M.; Nigro S.; Vescio B.; Arcuri P.P.; De Micco R.; Cirillo M.; Weis L.; Fiorenzato E.; Biundo R.; Burciu R.G.; Krismer F.; McFarland N.R.; Mueller C.; Gizewski E.R.; Cosottini M.; Del Prete E.; Mazzucchi S.; Quattrone A./titolo:Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease/doi:10.1002%2Fmds.28992/rivista:Movement disorders (Online)/anno:2022/pagina_da:1272/pagina_a:1281/intervallo_pagine:1272–1281/volume:37

Background: Differentiating progressive supranuclear palsy-parkinsonism (PSP-P) from Parkinson's disease (PD) is clinically challenging. Objective: This study aimed to develop an automated Magnetic Resonance Parkinsonism Index 2.0 (MRPI 2.0) algorith

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e16b259991f5d2c0d244bb037d42ac
https://doi.org/10.1002/mds.28992

Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes

Autor: Marta Campagnolo, Luca Weis, Carmelo Fogliano, Valeria Cianci, Michela Garon, Eleonora Fiorenzato, Miryam Carecchio, Florinda Ferreri, Patrizia Bisiacchi, Angelo Antonini, Roberta Biundo

The International Parkinson’s and Movement Disorder Society (MDS) criteria for progressive supranuclear palsy (PSP) have broadened the clinical spectrum of the disease and established phenotypic characterization according to the predominant manifes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::906f01c89303fee5d95c3f5a742d90d7
https://hdl.handle.net/11577/3467088